Breast cancer - bevacizumab (in combination with a taxane): response to consultee, commentator and public comments on the ACD and comments from website consultation

Breast cancer - bevacizumab (in combination with a taxane): response to consultee, commentator and public comments on the ACD and comments from website consultation

Breast cancer - bevacizumab (in combination with a taxane): response to consultee, commentator and public comments on the ACD and comments from website consultation
08 December 2010
(185.91 Kb 54 sec)

Adobe Acrobat reader required.

Adobe Acrobat reader required.

This page was last updated: 08 December 2010